Late-breaking exploratory analysis from the CANVAS Program presented at the American College of Cardiology’s 67th Annual Scientific Session The results of recent analysis showed that canagliflozin significantly reduced the risk of cardiovascular (CV) death or hospitalization for heart failure (HHF) in patients with type 2 diabetes (T2D) at high CV risk. This exploratory analysis from...
Positive results were announced this week from the study of a new insulin pump with a predictive low glucose suspend (PLGS) feature. Data showed that the system achieved the primary outcome of reducing time spent in hypoglycemia compared to sensor-augmented pump therapy alone. The company developing the device, Tandem Diabetes Care, is marketing its new...
The U.S. Food and Drug Administration (FDA) approved semaglutidea once-weekly glucagon-like peptide (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. The drug, produced by Novo Nordisk and marketed as OZEMPIC®, is administered once weekly, on the same day each week, and can be taken...
The results show that continuous glucose monitoring is an effective diabetes management tool that could benefit millions of people with type 2 diabetes on insulin therapy People with type 2 diabetes on a multiple daily injection (MDI) insulin therapy benefit from the use of continuous glucose monitoring (CGM), according to a study recently published in...
Researchers at Brigham and Women’s Hospital (BWH) recently published a study demonstrating the potential clinical utility of glycated CD59 (GCD59) as a novel biomarker for the screening and diagnosis of gestational diabetes mellitus (GDM). The data from this study showed that a single blood test that measures plasma GCD59 at week 24-28 of gestation identified...
Keeping the modern research lab up to date as the technology evolves can often be a full-time job. Since most scientists would rather be focused on their research, Endocrine News has compiled a few of the coolest gadgets to make your lab life a little easier. Choosing the best equipment for your laboratory can...
A new competition to bring innovation into the daily lives of type 2 diabetes patients was launched on April 10. The Alexa Diabetes Challenge is calling on innovators to create Alexa voice-enabled solutions to improve the lives of those with type 2 diabetes. The $250,000, multi-stage, prize competition is sponsored by Merck & Co., and...
You might have made hotel reservations or downloaded music from your smart phone or tablet, but now you even have the ability to conduct your research from the palm of your hand. The mobile era has arrived — smart phones and tablets have taken over many day-to-day activities, from ordering takeout to scanning digital boarding...
You might have made hotel reservations or downloaded music from your smart phone or tablet, but now you even have the ability to conduct your research from the palm of your hand. The mobile era has arrived — smart phones and tablets have taken over many day-to-day activities, from ordering takeout to scanning digital boarding...
